Home » today » News » Börse Express – New York Stocks Outlook: Little Move Before US Interest Rate Decision

Börse Express – New York Stocks Outlook: Little Move Before US Interest Rate Decision

video-tag-article">

NEW YORK (dpa-AFX) – A few hours before the US Federal Reserve’s interest rate decision, US trading venues are likely to remain broadly calm on Wednesday. The increase in interest rates by monetary authorities is expected to have a significant impact on the stock market, experts said. Against this backdrop, investors have recently continued to hold back.

About half an hour before Wall Street trading began, slight gains were reported. The broker IG has rated the leading US index Dow Jones Industrial 0.3 percent higher to 30,809.4 points. Nasdaq 100 interest-sensitive technology stocks it tended to be 0.1 percent higher at 11,868.8 points. The stock market barometers therefore tended to limit the previous day’s losses.

“What the Fed is doing, the European Central Bank must ultimately copy to prevent the euro from falling further,” commented Jochen Stanzl, market analyst at CMC Markets. If the pace is too high, the Fed could set in motion a spiral that could stall the global economy. A full percentage point increase should cause big waves in the market, as Stanzl warns.

Jürgen Molnar, a capital markets strategist at Robomarkets, thinks a 0.75 percentage point rate hike in the US is probably the best thing that can happen to the market. Most experts currently expect such a step. Only a minority think a whole point is possible. Speculation about even tighter monetary policy has recently gotten loud after the US inflation rate was higher than expected.

After the partial mobilization of the Russian military, investors should also keep an eye on armor values. Documents from Boeing
General dynamics Lockheed Martin
Northrop Grumman or Raytheon Technologies could take advantage of it.

Prior to the start of trading, Sotera Health’s shares stood out in the largely immobile market out. The service provider to the healthcare and pharmaceutical industry has lost a legal dispute over possible carcinogenic emissions from one of its facilities. The group, which has to pay the interested party about $ 345 million, filed an appeal; In light of the more than 700 pending cases, however, investors should expect further sensitive sanctions, JPMorgan analyst Casey Woodring wrote. Shares of Sotera Health lost about three percent in pre-market trading after losing double-digit percentages the previous day./jcf/tav/jha/

 ISIN  US2605661048  XC0009694271  US6311011026  US78378X1072

AXC0208 2022-09-21 / 15: 07

Copyright dpa-AFX business news GmbH. All rights reserved. Redistribution, republication or permanent storage is not permitted without the prior express consent of dpa-AFX.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.